Metabotropic glutamate receptor agonists for schizophrenia.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18245019.
- Also identified by DOI 10.1192/bjp.bp.107.045088.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A drug acting at metabotropic glutamate receptors has recently been reported to be an effective antipsychotic, breaking the rule that only dopamine receptor-blocking drugs have this property. The finding complements accumulating evidence that glutamatergic abnormalities are important in the pathophysiology of schizophrenia.
Medical subject headings
- Antipsychotic Agents
- Benzodiazepines
- Receptors, Metabotropic Glutamate
- Schizophrenia